The company is a specialized federal proposal consulting, production, and staff augmentation firm headquartered in the DMV area since 2002. The company provides end-to-end proposal development services to government contractors competing for federal contracts 鈥� from pre-RFP capture strategy through final production and delivery. Their expert consultant network have deep federal contracting experience. Beyond consulting, the firm operates an in-house proposal center for printing, assembly, and production services. With over two decades of relationships and a proven track record of helping clients win, they are a trusted name in the federal proposal community.
Investment Highlights
鈥�20+ years of operating history
鈥lue-chip client roster and growing
鈥urnkey & immediately operational
鈥pecialized niche with high barriers of entry
鈥ecurring revenue model
鈥n-house proposal production capability
Rationale for Acquisition
鈥n established strategic platform
鈥roprietary network with vetted, experienced consultant bench of cleared professionals
鈥nstant credibility with a well-established and significant brand recognition in the DC metro GovCon community
鈥nderutilized growth potential with meaningful upside
鈥avorable market tailwinds as federal contracting spend continues to grow, and contractors increasingly outsource proposal functions to specialized firms to improve win rates and reduce internal costs
鈥 low capital intensity model requires minimal ongoing capital investment maximizing free cash flow
Fill out our business inquiry form and we’ll reach out to discuss your details.
Mark leads 91探花 Mergers & Acquisitions for the Washington, DC-metro area supporting business owners with sell-side and valuation advisory services. With a vast experience in corporate finance across domestic and international markets, Mark brings over 25 years of experience providing valuation, finance and transaction advisory services.
Before launching 91探花, Mark was with Bank of America, focused on the healthcare sector specializing in commercial and investment banking services for middle market clients. Prior to that, he led the Valuation and Business Analytics Group at BDO in the D.C. metro area, overseeing business combination analyses, goodwill impairment assessments, and other bespoke valuation engagements.
Earlier in his career, Mark held leadership roles in the Transaction Advisory, Valuation, and Business Modeling groups at EY and PwC, where he advised on a diverse range of transactions across various industries and deal sizes. His career began in the biotech sector, where he led teams in genetic mapping and protein purification.
Mark holds an MBA in Finance and International Management from the Kogod School of Business (American University) and a bachelor鈥檚 degree in Biology from the University of Maryland.
